STRATEC Biomedical AG 

27.01.2012 20:09

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

1st voting rights announcement

Threadneedle Investment Funds ICVC, London, UK, has notified us pursuant to § 21 sec. 1 WpHG on 25 January 2012, that on 19 January 2012 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001, fell below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.71% (550,051 shares). These voting rights are directly held by Threadneedle Investment Funds ICVC.

2nd voting rights anouncement

Threadneedle Investment Services Limited, London, UK, has notified us pursuant to § 21 sec. 1 WpHG on 25 January 2012, that on 19 January 2012 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001, fell below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.71% (550,051 shares). Pursuant to § 22 para. 1 sent. 1 No. 6 WpHG, these voting rights are in their entirety attributable to Threadneedle Investment Services Limited, London, UK. These voting rights are directly held by Threadneedle Investment Funds ICVC.



27.01.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  

---